Corrigendum to: Autonomic symptoms in patients with moderate and severe chronic obstructive pulmonary disease (Acta Clinica Belgica, (2018), 73, 3, (182-190), 10.1080/17843286.2017.1379255);Autonomic symptoms in patients with moderate and severe chronic obstructive pulmonary disease

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine

Volumn 73, Issue 3, 2018, Pages 182-190

  Mohammed, Jibril ^a,b   Derom, Eric ^c   De Wandele, Inge ^c   Rombaut, Lies ^c   Calders, Patrick ^a  

^a GHENT UNIVERSITY   (Belgium)

^b BAYERO UNIVERSITY   (Nigeria)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Autonomic nervous system; chronic obstructive; health status; pulmonary disease; symptoms

Indexed keywords

CORTICOSTEROID; INSULIN;

ADULT; AGED; ANXIETY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEMALE; FORCED VITAL CAPACITY; GASTROINTESTINAL SYMPTOM; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERCHOLESTEROLEMIA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; ORTHOSTATIC INTOLERANCE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SHORT FORM 36; SMOKING; URINARY TRACT DISEASE; VASOMOTOR DISORDER; AUTONOMIC NERVOUS SYSTEM; CASE CONTROL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; AUTONOMIC NERVOUS SYSTEM; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85029896475     PISSN: 17843286     EISSN: 22953337     Source Type: Journal    
DOI: 10.1080/17843286.2017.1396392     Document Type: Erratum

References (40)

1. Borghi-Silva A, Mendes RG, Trimer R, et al. Potential effect of 6 vs. 12-weeks of physical training on cardiac autonomic function and exercise capacity in chronic obstructive pulmonary disease. Eur J Phys Rehabil Med. 2014. Epub 2014/03/07 PubMed PMID: 24594853.
2. van Gestel AJR, Kohler M, Steier J, et al. The effects of controlled breathing during pulmonary rehabilitation in patients with COPD. Respiration. 2012;83(2):115–124. doi:10.1159/000324449. PubMed PMID: WOS:000300306300006.
3. Andreas S, Anker SD, Scanlon PD, et al. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest. 2005;128(5):3618–3624.10.1378/chest.128.5.3618
4. Mohammed J, Meeus M, Derom E, et al. Evidence for autonomic function and its influencing factors in subjects with COPD: a systematic review. Respir Care. 2015;60(12):1841–1851. Epub 2015/10/22. doi: 10.4187/respcare.04174. PubMed PMID: 26487747.
5. Gimeno-Santos E, Rodriguez DA, Barberan-Garcia A, et al. Endurance exercise training improves heart rate recovery in patients with COPD. COPD. 2014;11(2):190–196. Epub 2014/01/01. doi: 10.3109/15412555.2013.831401. PubMed PMID: 24377907.
6. Costes F, Roche F, Pichot V, et al. Influence of exercise training on cardiac baroreflex sensitivity in patients with COPD. Eur Respir J. 2004;23(3):396–401. doi:10.1183/09031936.04.00040304.
7. Stewart AG, Marsh F, Waterhouse JC, et al. Autonomic nerve dysfunction in copd as assessed by the acetylcholine sweat-spot test. Eur Respir J. 1994;7(6):1090–1095. PubMed PMID: WOS:A1994NT24200011.
8. Raupach T, Bahr F, Herrmann P, et al. Slow breathing reduces sympathoexcitation in COPD. Eur Respir J. 2008;32(2):387–392. doi:10.1183/09031936.00109607. PubMed PMID: 18385175.
9. Müllerova H, Agusti A, Erqou S, et al. Cardiovascular comorbidity in COPD. Chest. 2013;144(4):1163–1178.10.1378/chest.12-2847
10. Dart AM, Du X-J, Kingwell BA. Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res. 2002;53(3):678–687.10.1016/S0008-6363(01)00508-9
11. Suarez GA, Opfer-Gehrking TL, Offord KP, et al. The autonomic symptom profile: a new instrument to assess autonomic symptoms. Neurology. 1999;52(3):523. doi:10.1212/wnl.52.3.523.
12. Blackett P, Rundle A, Frane J, et al. Body mass index (BMI) in Turner syndrome before and during growth hormone (GH) therapy. Int J Obesity. 2000;24(2):232–235.10.1038/sj.ijo.0801119
13. Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy a population-based study. Diabetes Care. 2004;27(12):2942–2947.10.2337/diacare.27.12.2942
14. Biegstraaten M, van Schaik IN, Wieling W, et al. Autonomic neuropathy in Fabry disease: a prospective study using the autonomic symptom profile and cardiovascular autonomic function tests. BMC Neurol. 2010;10(1):622–630.10.1186/1471-2377-10-38
15. De Wandele I, Rombaut L, Malfait F, et al. Clinical heterogeneity in patients with the hypermobility type of Ehlers-Danlos syndrome. Res Dev Disabil. 2013;34(3):873–881.10.1016/j.ridd.2012.11.018
16. Sletten DM, Suarez GA, Low PA, et al, editors. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clinic Proceedings; Elsevier; 2012;87(12):1196–1201.
17. Verbaan D, Marinus J, Visser M, et al. Patient-reported autonomic symptoms in Parkinson disease. Neurology. 2007;69(4):333–341.10.1212/01.wnl.0000266593.50534.e8
18. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235–245.10.1016/S1474-4422(06)70373-8
19. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD. Chest. 2008;134(4):43S–56S.10.1378/chest.08-0342
20. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153(3):976–980.10.1164/ajrccm.153.3.8630582
21. Niklasson A, Strid H, Simrén M, et al. Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease. Eur J Gastroenterol Hepatol. 2008;20(4):335–341.10.1097/MEG.0b013e3282f2d0ec
22. Ramos-Casals M, Stone JH, Moutsopoulos HM. Sjögren’s syndrome: diagnosis and therapeutics. London: Springer-verlag; 2012.
23. Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulmonary Med. 2012;12(1):1255–1263.10.1186/1471-2466-12-26
24. Suarez GA, Opfer-Gehrking T, Offord K, et al. The autonomic symptom profile: a new instrument to assess autonomic symptoms. Neurology. 1999;52(3):523–528.10.1212/WNL.52.3.523
25. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(5):1256–1276.
26. Spinhoven P, Ormel J, Sloekers P, et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27(2):363–370.10.1017/S0033291796004382
27. Bültmann U, de Vries M, Beurskens AJ, et al. Measurement of prolonged fatigue in the working population: determination of a cutoff point for the checklist individual strength. J Occup Health Psychol. 2000;5(4):411–416.10.1037/1076-8998.5.4.411
28. Bestall J, Paul E, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.10.1136/thx.54.7.581
29. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–483.10.1097/00005650-199206000-00002
30. Novak V, Spies JM, Novak P, et al. Hypocapnia and cerebral hypoperfusion in orthostatic intolerance. Stroke. 1998;29(9):1876–1881.10.1161/01.STR.29.9.1876
31. I, De Wandele, P, Calders, W, Peersman, et al, editors. Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls. Semin Arthritis Rheum. 2014.
32. Kapoor WN. Syncope. N Engl J Med. 2000;343(25):1856–1862.10.1056/NEJM200012213432507
33. Cannizzaro G, Garbin L, Clivati A, et al. Correction of hypoxia and hypercapnia in COPD patients: effects on cerebrovascular flow. Monaldi Archives for Chest Disease = Archivio Monaldi per le malattie del torace. 1997;52(1):9–12.
34. Mandl T, Granberg V, Apelqvist J, et al. Autonomic nervous symptoms in primary Sjogren's; syndrome. Rheumatology. 2008;47(6):914–919.10.1093/rheumatology/ken107
35. Benrud-Larson LM, Dewar MS, Sandroni P, et al, editors. Quality of life in patients with postural tachycardia syndrome. Mayo Clinic Proceedings; Elsevier; 2002;77(6):531–537.
36. Bir LS, Özkurt S, Daloglu G, et al. Impaired sympathetic skin response in chronic obstructive pulmonary disease. Tohoku J Exp Med. 2005;207(4):243–248. PubMed PMID: 16272793.10.1620/tjem.207.243
37. Pagani M, Lucini D, Pizzinelli P, et al. Effects of aging and of chronic obstructive pulmonary disease on RR interval variability. J Auton Nerv Syst. 1996;59(3):125–132. doi:10.1016/0165-1838(96)00015-x. PubMed PMID: WOS:A1996UW80800005.
38. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141(2):122–131.10.1016/j.ijcard.2009.09.543
39. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatric Psychiatry. 2001;16(5):451–454.10.1002/(ISSN)1099-1166
40. van Gestel AJR, Steier J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD). J Thoracic Dis. 2010;2(4):215–222. doi:10.3978/j.issn.2072-1439.2010.02.04.5. PubMed PMID: PMC3256465.